Physician
Dermatology
Dr. Helen M. Torok, MD
|
|
Give Review
Helen M. Torok practices Dermatology. She researched medicine at The Ohio State University College of Medicine. She has 2 awards "Fellow (FAAD)" and "Fellow (FASDS)". Helen M. Torok, MD is also published. She has 16 publications published. The lastest publication: "Extended-release Formulation of Minocycline in the Treatment of Moderate-to-severe Acne Vulgaris in Patients Over the Age of 12 Years.' Dr. Helen M. Torok is registered with Medicare.
Publications
- Extended-release Formulation of Minocycline in the Treatment of Moderate-to-severe Acne Vulgaris in Patients Over the Age of 12 Years.
- Safety and efficacy of micronized tretinoin gel (0.05%) in treating adolescent Acne.
- The Nicomide Improvement in Clinical Outcomes Study (NICOS): results of an 8-week trial.
- Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea.
- Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.
- Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in Atopic dermatitis.
- Improved quality of life with effective treatment of facial melasma: the pigment trial.
- Rosacea Skin care.
- Dose-ranging efficacy of new once-daily extended-release minocycline for Acne vulgaris.
- Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
- Community-based trial of a triple-combination agent for the treatment of facial melasma.
- A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC...
- Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea.
- A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream.
- Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial Acne vulgaris.
Schools
Ohio State University College of Medicine
Akron Genl Hospital
Case Western Reserve University
Procedures Preformed
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Non-Cosmetic Chemodenervation
- Shaving of Skin Lesion
- View All
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- Fellow (FAAD)
- Fellow (FASDS)
Education
-
Case Western Reserve University - University Hospitals -
Akron General Medical Center -
The Ohio State University College of Medicine
Hospital
-
Medina Hospital -
Wooster Community Hospital
Drug Facts
| NPI NUMBER | 1235198698 | |
| NPPES Provider LastName | TOROK | |
| NPPES Provider FirstName | HELEN | |
| NPPES Provider ZIPCode | 44256 | |
| NPPES Provider State | OH | |
| Specialty Description | Dermatology | |
| Total Claim Count | 1073.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235198698 |
| Last Name Of The Provider | TOROK |
| First Name Of The Provider | HELEN |
| View All |
Similar Doctors
|
Dr. Jennifer L. Popovsky, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick M. Killian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jay C. Klemme, MD
This Doctor is OpenDoctor Recommended.
|